Drug Profile
Somatropin polysialic - Xenetic Biosciences/SynBio
Alternative Names: Polysialic somatropin; SYN-20100504RULatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Xenetic Biosciences
- Developer SynBio; Xenetic Biosciences
- Class Growth hormones; Hormonal replacements; Obesity therapies; Recombinant proteins
- Mechanism of Action Human growth hormone replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase Unknown Somatotropin deficiency